Richard Anziano, M.Sc.

Scientific Advisor

Portrait-of-Richard-Anziano_Pharmetheus-1

Bio

  • Joined Pharmetheus in 2019, advising in client projects and training Pharmetheus colleagues in statistics
  • Expertise includes statistics, model-informed drug development, and trial design in therapeutic areas such as neuroscience, pain, and infectious diseases
  • Previously worked as Chief Statistician at Pharmetheus, Global Head of Statistics and Chief Statistician at Pfizer Incorporated, USA, where he led quantitative assessment of late stage probabilities of technical and regulatory success through modeling and simulation for all late stage assets compared to industry or therapeutic area benchmarks, Member of the Statistics Leadership at Pfizer Incorporated, USA, and Lead Statistician at Pfizer Incorporated, USA
  • M.Sc. in Statistics (1993) from University of Connecticut, USA
LinkedInGoogle Scholar

Pharmetheus affiliated publications

Benchmarking a mechanistic immunogenicity framework: aligning sequence-based epitope predictions with clinical observationsExposure-response analysis for time-to-event data in the presence of adaptive dosing: efficient approaches and pitfalls (Poster)Model Informed Drug Development: Collaboration Through A Common Framework